Shu Pan
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
Papers in
- Surgery 18
- Tissue Engineering and Regenerative Medicine 13
-
- Tracheal and airway disorders 14
- Co-authors
- Hongcan Shi (11 shared papers)Duxin Sun (6 shared papers)Bo Wen (4 shared papers)Houjun Xia (1 shared paper)Wei Li (1 shared paper)Guobin Wang (1 shared paper)Kaixiong Tao (1 shared paper)Takashi Tanikawa (1 shared paper)
- Journals
- Journal of Biomedical Materials Research Part A (3 papers)Scientific Reports (2 papers)Cell Metabolism (1 paper)International Journal of Biological Macromolecules (1 paper)IEEE Access (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Shu Pan
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 204
- Biomaterials 172
- Immunology 230
- Toxicology 26
- Oncology 174
Countries citing papers authored by Shu Pan
This map shows the geographic impact of Shu Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Pan more than expected).
Fields of papers citing papers by Shu Pan
This network shows the impact of papers produced by Shu Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Pan. The network helps show where Shu Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 326 | |
| 2 | 2014 | 57 | |
| 3 | 2021 | 53 | |
| 4 | 2017 | 50 | |
| 5 | 2021 | 50 | |
| 6 | 2016 | 48 | |
| 7 | 2021 | 35 | |
| 8 | 2018 | 35 | |
| 9 | 2020 | 34 | |
| 10 | 2014 | 34 | |
| 11 | 2015 | 32 | |
| 12 | 2022 | 29 | |
| 13 | Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer. | 2018 | 28 |
| 14 | 2007 | 27 | |
| 15 | 2018 | 20 | |
| 16 | α-Mangostin Treats Early-Stage Adjuvant-Induced Arthritis of Rat by Regulating the CAP-SIRT1 Pathway in Macrophages | 2022 | 19 |
| 17 | 2020 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2019 | 15 | |
| 20 | 2023 | 14 |
About Shu Pan
Shu Pan is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Biomaterials, Molecular Biology and Ocean Engineering, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Tracheal and airway disorders (14 papers), Tissue Engineering and Regenerative Medicine (13 papers), Electrospun Nanofibers in Biomedical Applications (11 papers), Combustion and Detonation Processes (4 papers), Coal Properties and Utilization (4 papers), Flame retardant materials and properties (3 papers), Mesenchymal stem cell research (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Cancer Research (204 citations), Biomaterials (172 citations), Immunology (230 citations), Toxicology (26 citations) and Oncology (174 citations). Shu Pan has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Hongcan Shi, Duxin Sun, Bo Wen, Houjun Xia, Wei Li, Guobin Wang, Kaixiong Tao, Takashi Tanikawa, Ke Wu and Weiping Zou. Their work appears in journals such as Journal of Biomedical Materials Research Part A, Scientific Reports, Cell Metabolism, International Journal of Biological Macromolecules and IEEE Access.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.